Total
0
Shares
Little Green Pharma (ASX:LGP) - Managing Director, Fleta Solomon - The Market Herald
Managing Director, Fleta Solomon
Sourced: AUManufacturing
  • Medicinal cannabis company Little Green Pharma (LGP) has been granted a new manufacturing permit from the office of drug control
  • The manufacturing permit will allow the company to manufacture cannabis extracts for holders of Therapeutic Goods Administration (TGA) GMP manufacturing licences to produce medicinal cannabis products
  • The company is now waiting on the medicinal cannabis cultivation and production permit, which will allow Little Green to begin planting at its expanded facility
  • Little Green is up 19.4 per cent on the market today and is trading for 40 cents per share

Medicinal cannabis company, Little Green Pharma (LGP) has been granted a new manufacturing permit from the office of drug control.

The manufacturing permit will allow the company to manufacture cannabis extracts for holders of therapeutic goods administration (TGA) GMP manufacturing licences to produce medicinal cannabis products.

Little Green has an exclusive agreement with its GMP-licenced manufacturing partner to produce the products.

The permit is valid for one year and ends in March 2021. This new permit will also allow the company to commence in-house extraction once the next crop is harvested, which is set to reduce costs and improve efficiencies.

Managing Director Fleta Solomon said receiving this permit also gives the company the capability to manufacture cannabis extracts at its manufacturing premises.

"We are now only waiting for our expanded ODC Medicinal Cannabis Cultivation and Production Permit which, once granted, will allow us to begin first planting at our expanded cultivation facility and to significantly expand our production operations," she said.

"This increased production capacity will give Little Green Pharma the ability to meet both Australian and offshore demand for medicinal cannabis products," Fleta added.

The company is now waiting on the medicinal cannabis cultivation and production permit, which will allow Little Green to begin planting at its expanded facility.

Little Green is up 19.4 per cent on the market today and is trading for 40 cents per share at 1:03 pm AEST.


Subscribe


LGP by the numbers
More From The Market Herald
Atomo Diagnostics (ASX:AT1) - Founder, Managing Director & CEO, John Kelly - The Market Herald

" Atomo Diagnostics (ASX:AT1) receives TGA approval for COVID-19 test

Atomo Diagnostics (AT1) has received the tick of approval from the Australian Therapeutic Goods Administration (TGA) for its COVID-19 rapid antibody test.
Medibio (ASX:MEB) - Managing Director, Claude Solitario - The Market Herald

" Medibio (ASX:MEB) granted U.S. patent for stress monitor

Mental health tech company Medibio (MEB) has been granted a patent by the U.S. Patent and Trademark Office.
Getting enough sleep? Mental wellness app spikes 117 per cent with new signing

" Medibio’s (ASX:MEB) sleep software and study affected by COVID-19

Meditech company Medibio (MEB) has revealed it’s facing some setbacks due to the ongoing coronavirus pandemic.
Kazia Therapeutics (ASX:KZA) - CEO & Executive Director, Dr James Garner - The Market Herald

" Kazia Therapeutics’ (ASX:KZA) paxalisib obtains rare paediatric disease designation

Kazia Therapeutics (KZA) has obtained rare paediatric disease designation (RPDD) for paxalisib in treating a form of childhood brain cancer.